PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 44 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200 | -69.4% | 12,000 | -49.4% | 0.00% | -66.7% |
| Q2 2023 | $654 | -50.1% | 23,700 | -58.4% | 0.00% | +50.0% |
| Q1 2023 | $1,310 | +689.2% | 57,000 | +272.5% | 0.00% | +100.0% |
| Q4 2022 | $166 | -99.9% | 15,300 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $128,000 | +5.8% | 15,300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $121,000 | -59.7% | 15,300 | +20.5% | 0.00% | 0.0% |
| Q1 2022 | $300,000 | -33.5% | 12,700 | -3.8% | 0.00% | -50.0% |
| Q4 2021 | $451,000 | +93.6% | 13,200 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $233,000 | -40.9% | 13,200 | +50.0% | 0.00% | 0.0% |
| Q2 2021 | $394,000 | +52.1% | 8,800 | -12.0% | 0.00% | 0.0% |
| Q1 2021 | $259,000 | +28.9% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $201,000 | -42.4% | 10,000 | -49.5% | 0.00% | -50.0% |
| Q2 2020 | $349,000 | +181.5% | 19,800 | +12.5% | 0.00% | +100.0% |
| Q1 2020 | $124,000 | 0.0% | 17,600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $124,000 | +5.1% | 17,600 | +27.5% | 0.00% | 0.0% |
| Q1 2018 | $118,000 | +140.8% | 13,800 | +475.0% | 0.00% | – |
| Q4 2017 | $49,000 | +16.7% | 2,400 | 0.0% | 0.00% | – |
| Q3 2017 | $42,000 | +55.6% | 2,400 | 0.0% | 0.00% | – |
| Q2 2017 | $27,000 | -10.0% | 2,400 | 0.0% | 0.00% | – |
| Q1 2017 | $30,000 | -42.3% | 2,400 | 0.0% | 0.00% | – |
| Q4 2016 | $52,000 | +4.0% | 2,400 | 0.0% | 0.00% | – |
| Q3 2016 | $50,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $20,647,000 | 6.08% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $19,057,000 | 2.28% |
| Kynam Capital Management, LP | 519,212 | $4,377,000 | 0.92% |
| RTW INVESTMENTS, LP | 4,176,837 | $35,211,000 | 0.81% |
| Tri Locum Partners LP | 199,500 | $1,682,000 | 0.46% |
| Birchview Capital, LP | 38,000 | $320,000 | 0.22% |
| Gratus Capital, LLC | 206,113 | $1,738,000 | 0.18% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,651,887 | $30,785,000 | 0.17% |
| PDT Partners, LLC | 126,038 | $1,063,000 | 0.16% |
| FOX RUN MANAGEMENT, L.L.C. | 40,683 | $343,000 | 0.13% |